• GSK126: Selective EZH2 Inhibitor Transforming Cancer Epig...

  2025-10-22

  GSK126 is a best-in-class selective EZH2/PRC2 inhibitor, delivering robust and precise disruption of cancer-driving epigenetic silencing. Its superior potency against EZH2-mutant tumors and compatibility with advanced experimental models empower researchers to decode PRC2 signaling and accelerate oncology drug development.

• Advancing Native Protein Analysis: Innovations with the B...

  2025-10-21

  Discover how the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) revolutionizes native polyacrylamide gel electrophoresis for proteins with PI ≤ 7.0, preserving activity for advanced biochemical analysis. This article uniquely explores mechanistic innovations and translational opportunities in protein research.

77 records 6/6 page Previous First page 上5页 6